So many stories are coming out of the UK and Canada about the lethal consequences of turning health care over to cost/benefit/best practices control panels, that we ignore them at our very real peril. The Globe and Mail reports today about women being cut off from drug combo treatments to treat a lethal lung disease due to cost—not efficacy. One is now close to death.
We have been warned. More details over at Secondhand Smoke .